SEI Investments’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-57,566
Closed -$2.94M 2863
2024
Q4
$2.94M Buy
57,566
+727
+1% +$35.7K ﹤0.01% 1523
2024
Q3
$2.34M Buy
56,839
+885
+2% +$42.5K ﹤0.01% 1614
2024
Q2
$2.69M Buy
+55,954
New +$2.48M ﹤0.01% 1517
2024
Q1
Sell
-97,131
Closed -$6.31M 2714
2023
Q4
$6.31M Sell
97,131
-44,161
-31% -$2.66M 0.01% 1078
2023
Q3
$9.24M Buy
141,292
+10,670
+8% +$671K 0.02% 894
2023
Q2
$7.59M Sell
130,622
-18,808
-13% -$1.19M 0.01% 1002
2023
Q1
$9.23M Buy
+149,430
New +$8.97M 0.02% 890
2022
Q4
Sell
-214,294
Closed -$15.6M 2702
2022
Q3
$15.6M Buy
214,294
+28,817
+16% +$2.15M 0.03% 563
2022
Q2
$12.6M Buy
+185,477
New +$13.3M 0.03% 667
2021
Q3
Sell
-5,455
Closed -$509K 2646
2021
Q2
$509K Buy
5,455
+1,015
+23% +$98.4K ﹤0.01% 2088
2021
Q1
$475K Buy
+4,440
New +$461K ﹤0.01% 2054
2020
Q4
Sell
-6,894
Closed -$476K 2548
2020
Q3
$476K Buy
+6,894
New +$443K ﹤0.01% 1908

Other funds holding NARI

SEI Investments's NARI Position: Q1 2025 in Review

SEI Investments sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 57,566 shares — an estimated $2.94M sold.

SEI Investments first reported a position in NARI in Q3 2020 and held it in 12 quarters. The position peaked at $15.6M in Q3 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • SEI Investments reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • SEI Investments sold 57,566 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.94M.
  • SEI Investments first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • SEI Investments's Inari Medical, Inc. Common Stock position peaked at $15.6M in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on SEI Investments's 13F filing for Q1 2025, filed 13 May 2025.